Drug reactions. 18. Cutaneous reactions to antituberculous drugs.
D000636:Aminosalicylic Acids / Q000009:adverse effects; D000995:Antitubercular Agents / Q000009:adverse effects*; D002207:Capreomycin / Q000009:adverse effects; D003523:Cycloserine / Q000009:adverse effects; D003875:Drug Eruptions; D004977:Ethambutol / Q000009:adverse effects; D005000:Ethionamide / Q000009:adverse effects; D006801:Humans; D007538:Isoniazid / Q000009:adverse effects; D007539:Isonicotinic Acids / Q000009:adverse effects; D007612:Kanamycin / Q000009:adverse effects; D011718:Pyrazinamide / Q000009:adverse effects; D012293:Rifampin / Q000009:adverse effects; D012867:Skin / Q000187:drug effects*; D013280:Stomatitis / Q000139:chemically induced; D013307:Streptomycin / Q000009:adverse effects; D013828:Thioacetazone / Q000009:adverse effects; D014756:Viomycin / Q000009:adverse effects
D000636:Aminosalicylic Acids; D000995:Antitubercular Agents; D007539:Isonicotinic Acids; D002207:Capreomycin; D011718:Pyrazinamide; D007612:Kanamycin; D004977:Ethambutol; D003523:Cycloserine; D013828:Thioacetazone; D005000:Ethionamide; D007538:Isoniazid; D012293:Rifampin; D013307:Streptomycin; D014756:Viomycin